Immunogenicity of the 9-Valent HPV Vaccine Using 2-Dose Regimens in Girls and Boys vs a 3-Dose Regimen in Women

---

Copy For Citation

Iversen O., Miranda M. J., Ulied A., Soerdal T., Lazarus E., Chokephaibulkit K., ...More

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, vol.316, no.22, pp.2411-2421, 2016 (SCI-Expanded)

• Publication Type: Article / Article
• Volume: 316 Issue: 22
• Publication Date: 2016
• Doi Number: 10.1001/jama.2016.17615
• Journal Name: JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• Page Numbers: pp.2411-2421
• Hacettepe University Affiliated: Yes

Abstract

IMPORTANCE Human papillomavirus (HPV) infections cause anogenital cancers and warts. The 9-valent HPV vaccine provides protection against 7 high-risk types of HPV responsible for 90% of cervical cancers and 2 other HPV types accounting for 90% of genital warts.